Routine sampling and analysis of newborn DNA would enable screening for hundreds of childhood genetic diseases, but also raises concerns about privacy and ethics.
Richard Scott, chief medical officer, acting CEO and soon to be the new interim CEO of Genomics England, has delved deep into the work the organisation does and how AI fits in ahead of speaking at the inaugural Digital Health AI and Data next week. Speaking to host Jordan Sollof on the Digital Health Unplugged podcast, Scott discussed his background and career to date and explained the work of Genomics England and the importance of AI before previewing his session at AI and Data on Monday 30 October. Scott is a trained doctor by background but confirmed that he was "really into genetics" and "did a project on genetics and my third year scientific bit was very much focused on genetics. "I didn't know that I'd end up so immersed in it (genetics/genomics), it was just one of those things that captured my imagination," he said. He eventually specialised in genomics and is now a clinical genetics consultant at Great Ormond Street. Whilst doing his PhD, &qu